OPINION - Psilocybin is different to other antidepressants — the Government is blocking patients who need it

Psilocybin saves lives. I have seen it with my own eyes on a clinical trial in London. One of the participants, a woman in her forties who had spent decades depressed, taking medications that left the illness untouched, felt bright and alive for the first time in years after just a single dose. But the government is blocking patient access.